Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review
Abstract
:1. Introduction
2. Focal Active Colitis in the Adult Setting
3. Focal Active Colitis in the Pediatric Setting
4. Clinical Implications of Focal Active Colitis
5. Differential Diagnosis
5.1. Healthy Colonic Mucosa
5.2. Acute Colitis
5.3. Early Onset Inflammatory Bowel Disease
5.4. Drug-Related Colitis, with Particular Attention to NSAIDs
5.5. Focal Active Colitis
5.6. Pseudomembranous Colitis
5.7. Hemorragic Colitis
5.8. Ischaemic Colitis
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Mandzhieva, B.; Taylor, J.; Zafar, H.; Rashid, M.U.; Khan, A.H. Focal Active Colitis Presented with Chronic Diarrhea. Cureus 2020, 12, e8140. [Google Scholar] [CrossRef]
- Greenson, J.K.; Stern, R.A.; Carpenter, S.L.; Barnett, J.L. The clinical significance of focal active colitis. Hum. Pathol. 1997, 28, 729–733. [Google Scholar] [CrossRef]
- Shetty, S.; Anjarwalla, S.M.; Gupta, J.; Foy, C.J.; Shaw, I.S.; Valori, R.M.; Shepherd, N.A. Focal active colitis: A prospective study of clinicopathological correlations in 90 patients. Histopathology 2011, 59, 850–856. [Google Scholar] [CrossRef]
- Volk, E.E.; Shapiro, B.D.; Easley, K.A.; Goldblum, J.R. The clinical significance of a biopsy-based diagnosis of focal active colitis: A clinicopathologic study of 31 cases. Mod. Pathol. 1998, 11, 789–794. [Google Scholar] [PubMed]
- Sinagra, E.; Raimondo, D.; Pompei, G.; Fusco, G.; Rossi, F.; Tomasello, G.; Leone, A.; Cappello, F.; Morreale, G.C.; Midiri, F.; et al. Focal active colitis as a predictor of inflammatory bowel disease: Results from a single-center experience. J. Biol. Regul. Homeost. Agents 2017, 31, 1119–1125. [Google Scholar] [PubMed]
- Hosack, T.; Griffiths, C.; Kumar, R.; Mandal, A.K.J.; Salam, I.; Missouris, C. The clinical significance of focal active colitis and inflammatory bowel disease. Preprint 2022. [Google Scholar] [CrossRef]
- Xin, W.; Brown, P.I.; Greenson, J.K. The clinical significance of focal active colitis in pediatric patients. Am. J. Surg. Pathol. 2003, 27, 1134–1138. [Google Scholar] [CrossRef]
- Osmond, A.; Ashok, D.; Francoeur, C.A.; Miller, M.; Walsh, J.C. Is focal active colitis of greater clinical significance in pediatric patients? A retrospective review of 68 cases with clinical correlation. Hum. Pathol. 2018, 74, 164–169. [Google Scholar] [CrossRef] [PubMed]
- Assarzadegan, N.; Montgomery, E.; Pezhouh, M.K. Colitides: Diagnostic challenges and a pattern based approach to differential diagnosis. Diagn. Histopathol. 2017, 23, 536–543. [Google Scholar] [CrossRef]
- Driman, D.K.; Preiksaitis, H.G. Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum. Pathol. 1998, 29, 972–978. [Google Scholar] [CrossRef]
- Marginean, E.C. The ever-changing landscape of drug-induced injury of the lower gastrointestinal tract. Arch. Pathol. Lab. Med. 2016, 140, 748–758. [Google Scholar] [CrossRef] [PubMed]
- Dhakhwa, R.; Shrestha, H.; Acharya, I. Histopathological evaluation of ulcerative colitis in colonoscopic biopsies. J. Pathol. Nepal 2016, 6, 932–936. [Google Scholar] [CrossRef]
- Ozdil, K.; Sahin, A.; Calhan, T.; Kahraman, R.; Nigdelioglu, A.; Akyuz, U.; Sokmen, H.M. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterol. 2011, 11, 96. [Google Scholar] [CrossRef]
- Jessurun, J. The Differential Diagnosis of Acute Colitis: Clues to a Specific Diagnosis. Surg. Pathol. Clin. 2017, 10, 863–885. [Google Scholar] [CrossRef] [PubMed]
- Surawicz, C.M. What’s the best way to differentiate infectious colitis (acute self-limited colitis) from IBD? Inflamm. Bowel Dis. 2008, 14, S157–S158. [Google Scholar] [CrossRef] [PubMed]
- Goldstein, N.S.; Cinenza, A.N. The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. Am. J. Clin. Pathol. 1998, 110, 622–628. [Google Scholar] [CrossRef]
- Higuchi, K.; Umegaki, E.; Watanabe, T.; Yoda, Y.; Morita, E.; Murano, M.; Tokioka, S.; Arakawa, T. Present status and strategy of NSAIDs-induced small bowel injury. J. Gastroenterol. 2009, 44, 879–888. [Google Scholar] [CrossRef]
- Klein, M.; Linnemann, D.; Rosenberg, J. Non-steroidal anti-inflammatory drug-induced colopathy. BMJ Case Rep. 2011, 2011, bcr1020103436. [Google Scholar] [CrossRef]
- McCarthy, A.J.; Lauwers, G.Y.; Sheahan, K. Iatrogenic pathology of the intestines. Histopathology 2015, 66, 15–28. [Google Scholar] [CrossRef]
- Dignan, C.R.; Greenson, J.K. Can ischemic colitis be differentiated from C difficile colitis in biopsy specimens? Am. J. Surg. Pathol. 1997, 21, 706–710. [Google Scholar] [CrossRef]
- Ochoa, T.J.; Cleary, T.G. Epidemiology and spectrum of disease of Escherichia coli O157. Curr. Opin. Infect. Dis. 2003, 16, 259–263. [Google Scholar] [CrossRef] [PubMed]
- Karmali, M.A.; Gannon, V.; Sargeant, J.M. Verocytotoxin-producing Escherichia coli (VTEC). Vet. Microbiol. 2010, 140, 360–370. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, Y.; Sperandio, V. Enterohemorrhagic E. coli (EHEC) pathogenesis. Front. Cell. Infect. Microbiol. 2012, 2, 90. [Google Scholar] [CrossRef]
- Pacheco, A.R.; Sperandio, V. Shiga toxin in enterohe-morrhagic E. coli: Regulation and novel anti-virulence strategies. Front. Cell Infect. Microbiol. 2012, 2, 81. [Google Scholar] [CrossRef] [PubMed]
- Högenauer, C.; Langner, C.; Beubler, E.; Lippe, I.T.; Schicho, R.; Gorkiewicz, G.; Krause, R.; Gerstgrasser, N.; Krejs, G.J.; Hinterleitner, T.A. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N. Engl. J. Med. 2006, 355, 2418–2426. [Google Scholar] [CrossRef]
- Cappell, M.S. Colonic toxicity of administered drugs and chemicals. Am. J. Gastroenterol. 2004, 99, 1175–1190. [Google Scholar] [CrossRef]
- Zou, X.; Cao, J.; Yao, Y.; Liu, W.; Chen, L. Endoscopic findings and clinicopathologic characteristics of ischemic colitis: A report of 85 cases. Dig. Dis. Sci. 2009, 54, 2009–2015. [Google Scholar] [CrossRef]
- Glauser, P.M.; Wermuth, P.; Cathomas, G.; Kuhnt, E.; Käser, S.A.; Maurer, C.A. Ischemic colitis: Clinical presentation, localization in relation to risk factors, and long-term results. World J. Surg. 2011, 35, 2549–2554. [Google Scholar] [CrossRef]
- Novello, M.; Mandarino, F.V.; Di Saverio, S.; Gori, D.; Lugaresi, M.; Duchi, A.; Argento, F.; Cavallari, G.; Wheeler, J.; Nardo, B. Post-operative outcomes and predictors of mortality after colorectal cancer surgery in the very elderly patients. Heliyon 2019, 5, e02363. [Google Scholar] [CrossRef]
- Shahini, E.; Sinagra, E.; Vitello, A.; Ranaldo, R.; Contaldo, A.; Facciorusso, A.; Maida, M. Factors affecting the quality of bowel preparation for colonoscopy in hard-to-prepare patients: Evidence from the literature. World J. Gastroenterol. 2023, 29, 1685–1707. [Google Scholar] [CrossRef]
- Maida, M.; Ventimiglia, M.; Facciorusso, A.; Vitello, A.; Sinagra, E.; Marasco, G. Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials. Dig. Liver Dis. 2023, 55, 1010–1018. [Google Scholar] [CrossRef] [PubMed]
- Maida, M.; Annibale, B.; Benedetti, A.; Burra, P.; Frulloni, L.; Ianiro, G.; Luzza, F.; Repici, A.; Savarino, E.; Sinagra, E.; et al. Quality of endoscopic screening for colorectal cancer in Italy: A national survey. Dig. Liver Dis. 2022, 54, 1410–1418. [Google Scholar] [CrossRef] [PubMed]
- Maida, M.; Morreale, G.C.; Sferrazza, S.; Sinagra, E.; Scalisi, G.; Vitello, A.; Vettori, G.; Rossi, F.; Catarella, D.; Di Bartolo, C.E.; et al. Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases. Dig. Liver Dis. 2021, 53, 1171–1177. [Google Scholar] [CrossRef]
- Sinagra, E.; Rossi, F.; Raimondo, D.; Conoscenti, G.; Anderloni, A.; Guarnotta, V.; Maida, M. Tenapanor for the treatment of irritable bowel syndrome with constipation. Expert Rev. Clin. Pharmacol. 2020, 13, 473–479. [Google Scholar] [CrossRef]
- Maida, M.; Sinagra, E.; Morreale, G.C.; Sferrazza, S.; Scalisi, G.; Schillaci, D.; Ventimiglia, M.; Macaluso, F.S.; Vettori, G.; Conoscenti, G.; et al. Effectiveness of very low-volume preparation for colonoscopy: A prospective, multicenter observational study. World J. Gastroenterol. 2020, 26, 1950–1961. [Google Scholar] [CrossRef] [PubMed]
- Sinagra, E.; Morreale, G.C.; Mohammadian, G.; Fusco, G.; Guarnotta, V.; Tomasello, G.; Cappello, F.; Rossi, F.; Amvrosiadis, G.; Raimondo, D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J. Gastroenterol. 2017, 23, 6593–6627. [Google Scholar] [CrossRef]
- Sinagra, E.; Pompei, G.; Tomasello, G.; Cappello, F.; Morreale, G.C.; Amvrosiadis, G.; Rossi, F.; Lo Monte, A.I.; Rizzo, A.G.; Raimondo, D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J. Gastroenterol. 2016, 22, 2242–2255. [Google Scholar] [CrossRef]
- Sinagra, E.; Romano, C.; Cottone, M. Psychopharmacological treatment and psychological interventions in irritable bowel syndrome. Gastroenterol. Res. Pract. 2012, 2012, 486067. [Google Scholar] [CrossRef]
- Ryan, F.J.; Ahern, A.M.; Fitzgerald, R.S.; Laserna-Mendieta, E.J.; Power, E.M.; Clooney, A.G.; O’Donoghue, K.W.; McMurdie, P.J.; Iwai, S.; Crits-Christoph, A.; et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat. Commun. 2020, 11, 1512. [Google Scholar] [CrossRef]
- Lavelle, A.; Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 223–237. [Google Scholar] [CrossRef]
- Tilg, H.; Zmora, N.; Adolph, T.E.; Elinav, E. The intestinal microbiota fuelling metabolic inflammation. Nat. Rev. Immunol. 2020, 20, 40–54. [Google Scholar] [CrossRef] [PubMed]
- Salmeri, N.; Sinagra, E.; Dolci, C.; Buzzaccarini, G.; Sozzi, G.; Sutera, M.; Candiani, M.; Ungaro, F.; Massimino, L.; Danese, S.; et al. Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together—A Review. Microorganisms 2023, 11, 2089. [Google Scholar] [CrossRef] [PubMed]
- Mandarino, F.V.; Sinagra, E.; Barchi, A.; Verga, M.C.; Brinch, D.; Raimondo, D.; Danese, S. Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease. Microorganisms 2023, 11, 1122. [Google Scholar] [CrossRef] [PubMed]
- Massimino, L.; Barchi, A.; Mandarino, F.V.; Spanò, S.; Lamparelli, L.A.; Vespa, E.; Passaretti, S.; Peyrin-Biroulet, L.; Savarino, E.V.; Jairath, V.; et al. A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis. J. Transl. Med. 2023, 21, 46. [Google Scholar] [CrossRef]
- Mandarino, F.V.; Testoni, S.G.G.; Barchi, A.; Pepe, G.; Esposito, D.; Fanti, L.; Viale, E.; Biamonte, P.; Azzolini, F.; Danese, S. Gastric emptying study before gastric peroral endoscopic myotomy (G-POEM): Can intragastric meal distribution be a predictor of success? Gut 2023, 72, 1019–1020. [Google Scholar] [CrossRef]
- Yao, K.; Iwashita, A.; Yao, T.; Takemura, S.; Furukawa, K.; Matsui, T.; Aoyagi, K. Increased numbers of macrophages in noninflamed gastroduodenal mucosa of patients with Crohn’s disease. Dis. Sci. 1996, 41, 2260–2267. [Google Scholar] [CrossRef]
- Tsurumi, K.; Matsui, T.; Hirai, F.; Takatsu, N.; Yano, Y.; Hisabe, T.; Sato, Y.; Beppu, T.; Fujiwara, S.; Ishikawa, S.; et al. Incidence, clinical characteristics, long-term course, and comparison of progressive and nonprogressive cases of aphthous-type Crohn’s disease: A single-center cohort study. Digestion 2013, 87, 262–268. [Google Scholar] [CrossRef]
- Oberhuber, G.; Püspök, A.; Oesterreicher, C.; Novacek, G.; Zauner, C.; Burghuber, M.; Vogelsang, H.; Potzi, R.; Stolte, M.; Wrba, F. Focally enhanced gastritis: A frequent type of gastritis in patients with Crohn’s disease. Gastroenterology 1997, 112, 698–706. [Google Scholar] [CrossRef]
Author, Year | Study Lenght | No. Patients | Infections | Drugs | Irritable Bowel Syndrome | Incidental | Inflammatory Bowel Disease | Other |
---|---|---|---|---|---|---|---|---|
Greenson, 1997 [2] | 1988–1993 | 42 | 55% | 45% | 14% | 26% | 0% | 5% |
Volk, 1997 [4] | 1982–1992 | 31 | 48% | ? | ? | 29% | 13% | 10% |
Shetty, 2011 [3] | 1994–2004 | 90 | 19% | 24% | 33% | 8% | 16% | - |
Sinagra, 2017 [5] | 2012–2016 | 30 | 3% | 30% | 27% | 17% | 23% | - |
Hosack, 2022 [6] | 2014–2019 | 43 | 33% | 7% | 19% | 26% | 12% | 2% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sinagra, E.; Mandarino, F.V.; Maida, M.; Cabibi, D.; Rossi, F.; Raimondo, D.; Manfredi, G., on behalf of the AIGO (Italian Association of Hospital Gastroenterologist) Young Committee. Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review. Biomedicines 2023, 11, 2631. https://doi.org/10.3390/biomedicines11102631
Sinagra E, Mandarino FV, Maida M, Cabibi D, Rossi F, Raimondo D, Manfredi G on behalf of the AIGO (Italian Association of Hospital Gastroenterologist) Young Committee. Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review. Biomedicines. 2023; 11(10):2631. https://doi.org/10.3390/biomedicines11102631
Chicago/Turabian StyleSinagra, Emanuele, Francesco Vito Mandarino, Marcello Maida, Daniela Cabibi, Francesca Rossi, Dario Raimondo, and Guido Manfredi on behalf of the AIGO (Italian Association of Hospital Gastroenterologist) Young Committee. 2023. "Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review" Biomedicines 11, no. 10: 2631. https://doi.org/10.3390/biomedicines11102631